Publication of Suppl.Prospcts
Source: RNS
The following base prospectus supplement has been approved by the UK Financial Conduct Authority and is available for viewing:
Third supplement (the "Third Supplement") to the base prospectus dated 13 July 2021 (as supplemented by the first supplement dated 12 November 2021 and the second supplement dated 28 February 2022, together the "Base Prospectus") relating to the £1,000,000,000 UK Debt Issuance Programme by NATIXIS and Natixis Structured Issuance S.A. (each an "Issuer" and together the "Issuers").
To view the full document, please paste the following URL into the address of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4200J_1-2022-4-26.pdf
The following information has been incorporated by reference into the Base Prospectus pursuant to the Third Supplement:
· The 2021 universal registration document and annual financial report of NATIXIS, being a free English translation of the document d'enregistrement universel 2021 that has been filed with the French Autorité des marchés financiers on 11 March 2022 under number D.22-0088:
https://cib.natixis.com/DevInet.PIMS.ComplianceTool.Web/api/ProspectusPublicNg/DownloadDocument/214/ISSUER_FINANCIAL_SEARCH
A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Name: Olivier Chomette
Email: olivier.chomette@natixis.com
Tel: +33 1 5855 55 50
Name: Déborah Ngo Yogo II
Email: deborah.ngoyogoii@natixis.com
Tel: +33 1 58 55 44 77
Name: Charlotte LETELLIER
Email: charlotte.letellier@natixis.com
Tel: +33 1 58 55 79 98
Name: Caroline DURUEL
Email: caroline.duruel@natixis.com
Tel: +33 1 58 55 46 70
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Base Prospectus and the Third Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus and the Third Supplement you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein. By accessing this document, you will be deemed to certify that you are located outside the United States and are not accessing the Base Prospectus from a location inside the United States.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
